Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

Boehringer Ingelheim launches AI centre in London

 April 20, 2026

Pharmaceutical Technology

The new site will focus on the use of AI models for purposes including the discovery and development of targeted medicines for patients with unmet medical needs.

OtherRead full story

Post navigation

Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal →
← AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com